Janssen Pharmaceutica N.v., Belgium
Clinical trials sponsored by Janssen Pharmaceutica N.v., Belgium, explained in plain language.
-
New drug combo may delay prostate cancer spread in high-risk patients
Disease control OngoingThis study tests whether adding apalutamide to standard radiation and hormone therapy can delay cancer spread or death in men with high-risk prostate cancer that has not yet spread. About 692 participants are involved. The approach aims to better control the disease, but ongoing …
Phase: PHASE3 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Real-World study compares two psoriatic arthritis drugs for staying power
Disease control OngoingThis study follows over 1,300 people with psoriatic arthritis to see how long they continue taking guselkumab (Tremfya) or a class of drugs called IL-17 inhibitors. Researchers are tracking joint swelling and tenderness to understand how well these treatments work in everyday med…
Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated May 13, 2026 16:01 UTC